Effect of quipazine, a serotonin-like drug, on striatal cholinergic interneurones
- 1 February 1977
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 41 (3) , 281-289
- https://doi.org/10.1016/0014-2999(77)90321-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The effects of quipazine on serotonin metabolism in rat brainLife Sciences, 1976
- Modulation of neostriatal acetylcholine in the rat by dopamine and 5-hydroxytryptamine afferentsLife Sciences, 1976
- Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviourNeuropharmacology, 1976
- Regional levels of choline and acetylcholine in rat brain following head focussed microwave sacrifice: Effect of (+)-amphetamine and (±)-parachloroamphetamineNeuropharmacology, 1976
- Quipazine: a serotoninergic hyperthermic agent in the rabbitJournal of Pharmacy and Pharmacology, 1976
- Regulation of striatal acetylcholine concentration by dopamine receptorsNature, 1974
- Involvement of brain cholinergic mechanisms in the action of chlorpromazineNature, 1974
- Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatumJournal of Pharmacy and Pharmacology, 1974
- In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatumJournal of Pharmacy and Pharmacology, 1974
- Influence of quipazine, a potential anti-parkinsonian agent on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitroLife Sciences, 1973